EVP People and Culture Sells ATEC 33K Shares for $679K

Company Overview - Alphatec Holdings, Inc. is a U.S.-based medical technology company that specializes in innovative solutions for spinal surgery, focusing on proprietary platforms and expanding its portfolio to address complex spinal conditions [6]. Insider Trading Activity - Craig E. Hunsaker, EVP of People & Culture at Alphatec Holdings, executed an open-market sale of 32,584 shares valued at $679,050.56 on December 10, 2025, at a price of $20.84 per share [4][5]. - This sale represented 2.53% of Hunsaker's direct ownership at the time, which is slightly below his historical median of 2.79% for sell trades [3]. - The transaction size was significantly below Hunsaker's recent median sale of 60,876 shares, indicating a smaller-than-usual transaction [4][5]. Market Performance - Alphatec's stock has seen a remarkable 116% rise over the last year, outperforming the S&P 500's 15% total return and the 2.8% decline in the State Street SPDR Health Care Equipment ETF [8]. - Despite a solid preliminary report in January 2026, the stock experienced a nearly 22% drop in one day due to a disappointing mid-teens growth projection, and the company remains unprofitable [9]. Strategic Developments - Alphatec recently announced a partnership with Theradaptive, granting it exclusive U.S. rights to commercialize the OsteoAdapt spinal fusion technology, which is still in clinical trials. This partnership could lead to surgeon adoption and revenue growth if successful [9].